1Q16 US Syndicated loan volume tumbles 19% y-o-y; Down a more substantial 37% q-o-q US syndicated loan volume took a tumble in 1Q16 to log just over $310 billion, down 19% compared to year ago levels and a more substantial 37% drop over 4Q15 totals. Surprisingly, the decline was most notable among investment grade issuers who…
Last Saturday a friend of ours took advantage of the spring-like weather, wading upstream from his house. Armed with his son’s $14.99 Shakespeare® Salamander rod, a can of worms, a six pack, and a cigar, he sat on a log, waiting for a nibble. Three hours – and zero nibbles – later, a man in…
This week we chat with Tim Kelly, a 30+ year veteran of private equity and capital markets. Since retiring as a senior investment Partner with Adams Street Partners, Tim has completed his Ph.D. in Organizational Psychology. His focus is what investors, LPs, GPs, and capital market participants can learn by applying new perspectives on people,…
Distressed debt and special situations funds show somewhat higher returns than direct lending funds, but carry significantly higher credit risk. Risk/Return by Strategy (Vintage 2003-2013 Funds) Source: Preqin Private Debt Online; sphere size represents market capitalization
????Click for a larger image.
As Investment Activity Slows, Competition for Quality Remains Fierce As March winds down, the first quarter of 2016 currently has seen around 700 private equity deals close in the U.S. Taking the total as 700, that completed deal count represents a drop of nearly 29% from the tally of 4Q 2015, which itself saw the…
There is no excerpt because this is a protected post.
Contact: Timothy Stubbs timothy.stubbs@spcapitaliq.com
Valeant Pharmaceuticals, the most widely held name in U.S. CLOs, announced last week it was cutting its revenue forecast and that a delay in filing its annual report put the company at risk of defaulting on its debt. In response, Valeant’s shares plunged by more than 50%. The company’s loans ended Tuesday with a weighted…